Lates News

Edgewise Therapeutics (EWTX.US): In the third quarter of 2025, the revenue reported was $0, unchanged from the previous quarter. The earnings per share were -$0.39, compared to -$0.34 in the previous quarter, and below the expected value of -$0.40.